Motor speech and non-motor language endophenotypes of Parkinson’s disease

References

• Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150–1157.
   PubMed Web of Science ®Google Scholar
• Cheng HC, Ulane CM, Burke RE. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010;67(6):715–725.
   PubMed Web of Science ®Google Scholar
• Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Healy DG, Schapira AH. National institute for clinical E. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–245.
   PubMed Web of Science ®Google Scholar
• Collaborators GBDPsD. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939–953.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.
   PubMed Web of Science ®Google Scholar
• Brabenec L, Mekyska J, Galaz Z, et al. Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm (Vienna). 2017;124(3):303–334.
   PubMed Web of Science ®Google Scholar
• Miller N, Noble E, Jones D, et al. Life with communication changes in Parkinson’s disease. Age Ageing. 2006;35(3):235–239.
   PubMed Web of Science ®Google Scholar
• Miller N, Allcock L, Jones D, et al. Prevalence and pattern of perceived intelligibility changes in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78(11):1188–1190.
   PubMed Web of Science ®Google Scholar
• Canter GJ. Speech characteristics of patients with parkinson’s disease: I. Intensity, pitch, and duration. J Speech Hear Disord. 1963;28:221–229.
   PubMedGoogle Scholar
• Canter GJ. Speech characteristics of patients with Parkinson’s disease. Ii. Physiological support for speech. J Speech Hear Disord. 1965;30:44–49.
   PubMedGoogle Scholar
• Darley FL, Aronson AE, Brown JR. Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res. 1969;12(3):462–496.
   PubMedGoogle Scholar
• Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. J Speech Hear Res. 1969;12(2):246–269.
   PubMedGoogle Scholar
• Obeso JA, Rodriguez-Oroz MC, Rodriguez M, et al. Pathophysiology of the basal ganglia in Parkinson’s disease. Trends Neurosci. 2000;23(10 Suppl):S8–19.
   PubMed Web of Science ®Google Scholar
• Baker KK, Ramig LO, Luschei ES, et al. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology. 1998;51(6):1592–1598.
   PubMed Web of Science ®Google Scholar
• Zarzur AP, Duprat AC, Shinzato G, et al. Laryngeal electromyography in adults with Parkinson’s disease and voice complaints. Laryngoscope. 2007;117(5):831–834.
   PubMed Web of Science ®Google Scholar
• De Letter M, Santens P, De Bodt M, et al. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson’s disease. Clin Neurol Neurosurg. 2007;109(6):495–500.
   PubMed Web of Science ®Google Scholar
• Ho AK, Bradshaw JL, Iansek R. For better or worse: the effect of levodopa on speech in Parkinson’s disease. Mov Disord. 2008;23(4):574–580.
   PubMed Web of Science ®Google Scholar
• Elfmarkova N, Gajdos M, Mrackova M, et al. Impact of Parkinson’s disease and levodopa on resting state functional connectivity related to speech prosody control. Parkinsonism Relat Disord. 2016;22(Suppl 1):S52–55.
   PubMedGoogle Scholar
• Skodda S, Gronheit W, Schlegel U. Intonation and speech rate in Parkinson’s disease: general and dynamic aspects and responsiveness to levodopa admission. J Voice. 2011;25(4):e199–205.
   PubMed Web of Science ®Google Scholar
• Muslimovic D, Post B, Speelman JD, et al. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005;65(8):1239.
   PubMed Web of Science ®Google Scholar
• Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain. 2007;130(Pt 7):1787–1798.
   PubMed Web of Science ®Google Scholar
• Janvin CC, Larsen JP, Aarsland D, et al. Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord. 2006;21(9):1343–1349.
   PubMed Web of Science ®Google Scholar
• Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson’s disease. Mov Disord. 2007;22(9):1272–1277.
   PubMed Web of Science ®Google Scholar
• Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837–844.
   PubMed Web of Science ®Google Scholar
• Muslimovic D, Schmand B, Speelman JD, et al. Course of cognitive decline in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc. 2007;13(6):920–932.
   PubMed Web of Science ®Google Scholar
• Uc EY, Rizzo M, Anderson SW, et al. Visual dysfunction in Parkinson disease without dementia. Neurology. 2005;65(12):1907–1913.
   PubMed Web of Science ®Google Scholar
• Kehagia AA, Barker RA, Robbins TW. Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis. Neurodegener Dis. 2013;11(2):79–92.
   PubMed Web of Science ®Google Scholar
• Lewis FM, Lapointe LL, Murdoch BE, et al. Language impairment in Parkinson’s disease. Aphasiology. 1998;12(3):193–206.
   Web of Science ®Google Scholar
• Auclair-Ouellet N, Lieberman P, Monchi O. Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson’s disease. Neurosci Biobehav Rev. 2017;80:657–672.
   PubMed Web of Science ®Google Scholar
• Copland D. The basal ganglia and semantic engagement: potential insights from semantic priming in individuals with subcortical vascular lesions, Parkinson’s disease, and cortical lesions. J Int Neuropsychol Soc. 2003;9(7):1041–1052.
   PubMed Web of Science ®Google Scholar
• Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov Disord. 2012;27(3):349–356.
   PubMed Web of Science ®Google Scholar
• Bayles KA. Language and Parkinson disease. Alzheimer Dis Assoc Disord. 1990;4(3):171–180.
   PubMedGoogle Scholar
• Murray LL, Rutledge S. Reading comprehension in Parkinson’s disease. Am J Speech Lang Pathol. 2014;23(2):S246–258.
   PubMed Web of Science ®Google Scholar
• Colman KS, Koerts J, Stowe LA, et al. Sentence comprehension and its association with executive functions in patients with Parkinson’s disease. Parkinsons Dis. 2011;2011:213983.
   PubMed Web of Science ®Google Scholar
• Angwin AJ, Chenery HJ, Copland DA, et al. Summation of semantic priming and complex sentence comprehension in Parkinson’s disease. Brain Res. 2005;25(1):78–89.
   Web of Science ®Google Scholar
• Kemmerer D. Impaired comprehension of raising-to-subject constructions in Parkinson’s disease. Brain Lang. 1999;66(3):311–328.
   PubMed Web of Science ®Google Scholar
• Ash S, Xie SX, Gross RG, et al. The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders. Neuropsychology. 2012;26(3):368–384.
   PubMed Web of Science ®Google Scholar
• Smith KM, Ash S, Xie SX, et al. Evaluation of linguistic markers of word-finding difficulty and cognition in Parkinson’s disease. J Speech Lang Hear Res. 2018;61(7):1691–1699.
   PubMed Web of Science ®Google Scholar
• Salmazo-Silva H, Parente MA, Rocha MS, et al. Lexical-retrieval and semantic memory in Parkinson’s disease: the question of noun and verb dissociation. Brain Lang. 2017;165:10–20.
   PubMed Web of Science ®Google Scholar
• Henry JD, Crawford JR. Verbal fluency deficits in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc. 2004;10(4):608–622.
   PubMed Web of Science ®Google Scholar
• Copland DA, Sefe G, Ashley J, et al. Impaired semantic inhibition during lexical ambiguity repetition in Parkinson’s disease. Cortex. 2009;45(8):943–949.
   PubMed Web of Science ®Google Scholar
• Angwin AJ, Chenery HJ, Copland DA, et al. The speed of lexical activation is altered in Parkinson’s disease. J Clin Exp Neuropsychol. 2007;29(1):73–85.
   PubMed Web of Science ®Google Scholar
• Kemmerer D, Miller L, Macpherson MK, et al. An investigation of semantic similarity judgments about action and non-action verbs in Parkinson’s disease: implications for the embodied cognition framework. Front Hum Neurosci. 2013;7:146–146.
   PubMed Web of Science ®Google Scholar
• Silveri MC, Ciccarelli N, Baldonero E, et al. Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson’s disease. Neuropsychologia. 2012;50(8):1980–1989.
   PubMed Web of Science ®Google Scholar
• Peran P, Cardebat D, Cherubini A, et al. Object naming and action-verb generation in Parkinson’s disease: a fMRI study. Cortex. 2009;45(8):960–971.
   PubMed Web of Science ®Google Scholar
• McDowd J, Hoffman L, Rozek E, et al. Understanding verbal fluency in healthy aging, Alzheimer’s disease, and Parkinson’s disease. Neuropsychology. 2011;25(2):210–225.
   PubMed Web of Science ®Google Scholar
• Boulenger V, Mechtouff L, Thobois S, et al. Word processing in Parkinson’s disease is impaired for action verbs but not for concrete nouns. Neuropsychologia. 2008;46(2):743–756.
   PubMed Web of Science ®Google Scholar
• Berg E, Bjornram C, Hartelius L, et al. High-level language difficulties in Parkinson’s disease. Clin Linguist Phon. 2003;17(1):63–80.
   PubMed Web of Science ®Google Scholar
• Ellis C, Crosson B, Gonzalez Rothi LJ, et al. Narrative discourse cohesion in early stage Parkinson’s disease. J Parkinsons Dis. 2015;5(2):403–411.
   PubMedGoogle Scholar
• Copland DA, Chenery HJ, Murdoch BE. Discourse priming of homophones in individuals with dominant nonthalamic subcortical lesions, cortical lesions and Parkinson’s disease. J Clin Exp Neuropsychol. 2001;23(4):538–556.
   PubMed Web of Science ®Google Scholar
• Metter EJ, Hanson WR. Clinical and acoustical variability in hypokinetic dysarthria. J Commun Disord. 1986;19(5):347–366.
   PubMed Web of Science ®Google Scholar
• Sapir S, Pawlas AA, Ramig LO, et al. Voice and speech abnormalities in Parkinson disease: relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. J Med Speech Lang Pathol. 2001;9(4):213–226.
   Google Scholar
• Rusz J, Cmejla R, Ruzickova H, et al. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am. 2011;129(1):350–367.
   PubMed Web of Science ®Google Scholar
• Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. St Louis (MO):  Elsevier Mosby; 2012.
   Google Scholar
• Forrest K, Weismer G, Turner GS. Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults. J Acoust Soc Am. 1989;85(6):2608–2622.
   PubMed Web of Science ®Google Scholar
• Fox CM, Ramig LO. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol. 1997;6(2):85–94.
   Google Scholar
• Skodda S, Gronheit W, Schlegel U, et al. Effect of subthalamic stimulation on voice and speech in Parkinson’s disease: for the better or worse? Front Neurol. 2014;4:218.
   PubMed Web of Science ®Google Scholar
• Ackermann H, Ziegler W. Articulatory deficits in parkinsonian dysarthria: an acoustic analysis. J Neurol Neurosurg Psychiatry. 1991;54(12):1093–1098.
   PubMed Web of Science ®Google Scholar
• Walsh B, Smith A. Linguistic complexity, speech production, and comprehension in Parkinson’s disease: behavioral and physiological indices. J Speech Lang Hear Res. 2011;54(3):787–802.
   PubMed Web of Science ®Google Scholar
• Benke T, Hohenstein C, Poewe W, et al. Repetitive speech phenomena in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;69(3):319–324.
   PubMed Web of Science ®Google Scholar
• Ackermann H, Hertrich I, Hehr T. Oral diadochokinesis in neurological dysarthrias. Folia Phoniatr Logop. 1995;47(1):15–23.
   PubMed Web of Science ®Google Scholar
• Ackermann H, Konczak J, Hertrich I. The temporal control of repetitive articulatory movements in Parkinson’s disease. Brain Lang. 1997;56(2):312–319.
   PubMed Web of Science ®Google Scholar
• Canter GJ. Speech characteristics of patients with parkinson’s disease. 3. Articulation, diadochokinesis, and over-all speech adequacy. J Speech Hear Disord. 1965;30:217–224.
   PubMedGoogle Scholar
• Dromey C, Ramig LO, Johnson AB. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study. J Speech Hear Res. 1995;38(4):751–764.
   PubMedGoogle Scholar
• Walsh B, Smith A. Basic parameters of articulatory movements and acoustics in individuals with Parkinson’s disease. Mov Disord. 2012;27(7):843–850.
   PubMed Web of Science ®Google Scholar
• Skodda S, Visser W, Schlegel U. Vowel articulation in Parkinson’s disease. J Voice. 2011;25(4):467–472.
   PubMed Web of Science ®Google Scholar
• Sapir S, Ramig LO, Spielman JL, et al. Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech. J Speech Lang Hear Res. 2010;53(1):114–125.
   PubMed Web of Science ®Google Scholar
• Fischer E, Goberman AM. Voice onset time in Parkinson disease. J Commun Disord. 2010;43(1):21–34.
   PubMed Web of Science ®Google Scholar
• Jimenez-Jimenez FJ, Gamboa J, Nieto A, et al. Acoustic voice analysis in untreated patients with Parkinson’s disease. Parkinsonism Relat Disord. 1997;3(2):111–116.
   PubMedGoogle Scholar
• Goberman AM, Blomgren M, Metzger E. Characteristics of speech disfluency in Parkinson disease. J Neurolinguistics. 2010;23(5):470–478.
   Web of Science ®Google Scholar
• Holmes RJ, Oates JM, Phyland DJ, et al. Voice characteristics in the progression of Parkinson’s disease. Int J Lang Commun Disord. 2000;35(3):407–418.
   PubMed Web of Science ®Google Scholar
• Gamboa J, Jimenez-Jimenez FJ, Nieto A, et al. Acoustic voice analysis in patients with Parkinson’s disease treated with dopaminergic drugs. J Voice. 1997;11(3):314–320.
   PubMed Web of Science ®Google Scholar
• Silva LF, Gama AC, Cardoso FE, et al. Idiopathic Parkinson’s disease: vocal and quality of life analysis. Arq Neuropsiquiatr. 2012;70(9):674–679.
   PubMed Web of Science ®Google Scholar
• Skodda S, Rinsche H, Schlegel U. Progression of dysprosody in Parkinson’s disease over time–a longitudinal study. Mov Disord. 2009;24(5):716–722.
   PubMed Web of Science ®Google Scholar
• Rojas Azocar S, Kefalianos E, Vogel AP. How does our voice change as we age? A systematic review and meta-analysis of vocal function of healthy adults over 50 years of age. J Speech Lang Hear Res (Submitted). 2019.
   Google Scholar
• Harel BT, Cannizzaro MS, Cohen H, et al. Acoustic characteristics of Parkinsonian speech: a potential biomarker of early disease progression and treatment. J Neurolinguistics. 2004;17(6):439–453.
   Web of Science ®Google Scholar
• Rusz J, Cmejla R, Ruzickova H, et al. Acoustic assessment of voice and speech disorders in Parkinson’s disease through quick vocal test. Mov Disord. 2011;26(10):1951–1952.
   PubMed Web of Science ®Google Scholar
• Goberman A, Coelho C, Robb M. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states. J Commun Disord. 2002;35(3):217–239.
   PubMed Web of Science ®Google Scholar
• Hammen VL, Yorkston KM. Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria. J Commun Disord. 1996;29(6):429–444;quiz 444–425.
   PubMed Web of Science ®Google Scholar
• Schulz GM. The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature. Curr Med Chem. 2002;9(14):1359–1366.
   PubMed Web of Science ®Google Scholar
• Cantiniaux S, Vaugoyeau M, Robert D, et al. Comparative analysis of gait and speech in Parkinson’s disease: hypokinetic or dysrhythmic disorders? J Neurol Neurosurg Psychiatry. 2010;81(2):177–184.
   PubMed Web of Science ®Google Scholar
• Hoodin RB, Gilbert HR. Nasal airflows in parkinsonian speakers. J Commun Disord. 1989;22(3):169–180.
   PubMed Web of Science ®Google Scholar
• Novotny M, Rusz J, Cmejla R, et al. Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson’s disease and Huntington’s disease. PeerJ. 2016;4:e2530.
   PubMed Web of Science ®Google Scholar
• Rusz J, Cmejla R, Ruzickova H, et al. Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy. J Neural Transm (Vienna). 2013;120(2):319–329.
   PubMed Web of Science ®Google Scholar
• Skodda S, Flasskamp A, Schlegel U. Instability of syllable repetition in Parkinson’s disease–influence of levodopa and deep brain stimulation. Mov Disord. 2011;26(4):728–730.
   PubMed Web of Science ®Google Scholar
• Ho AK, Iansek R, Marigliani C, et al. Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol. 1998;11(3):131–137.
   PubMed Web of Science ®Google Scholar
• Rusz J, Cmejla R, Tykalova T, et al. Imprecise vowel articulation as a potential early marker of Parkinson’s disease: effect of speaking task. J Acoust Soc Am. 2013;134(3):2171–2181.
   PubMed Web of Science ®Google Scholar
• Cohen H, Cannizzaro M, Harel B, et al. Acoustic characteristics of Parkinsonian speech as indicators of early disease progression and treatment. J Neurol Sci. 2006;248(1–2):285–285.
   Web of Science ®Google Scholar
• Skodda S, Gronheit W, Mancinelli N, et al. Progression of voice and speech impairment in the course of Parkinson’s disease: a longitudinal study. Parkinsons Dis. 2013;2013:389195.
   PubMedGoogle Scholar
• Skodda S, Flasskamp A, Schlegel U. Instability of syllable repetition as a marker of disease progression in Parkinson’s disease: a longitudinal study. Mov Disord. 2011;26(1):59–64.
   PubMed Web of Science ®Google Scholar
• Skodda S, Gronheit W, Schlegel U. Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS One. 2012;7(2):e32132.
   PubMed Web of Science ®Google Scholar
• Galaz Z, Mekyska J, Zvoncak V, et al. Changes in phonation and their relations with progress of Parkinson’s disease. Appl Sci. 2018;8(12):2339.
   Google Scholar
• Pinho P, Monteiro L, Soares M, et al. Impact of levodopa treatment in the voice pattern of Parkinson s disease patients: a systematic review and meta-analysis. CoDAS. 2018;30.
   PubMed Web of Science ®Google Scholar
• Perestelo-Perez L, Rivero-Santana A, Perez-Ramos J, et al. Deep brain stimulation in Parkinson’s disease: meta-analysis of randomized controlled trials. J Neurol. 2014;261(11):2051–2060.
   PubMed Web of Science ®Google Scholar
• Astrom M, Tripoliti E, Hariz MI, et al. Patient-specific model-based investigation of speech intelligibility and movement during deep brain stimulation. Stereotact Funct Neurosurg. 2010;88(4):224–233.
   PubMed Web of Science ®Google Scholar
• Putzer M, Barry WJ, Moringlane JR. Effect of bilateral stimulation of the subthalamic nucleus on different speech subsystems in patients with Parkinson’s disease. Clin Linguist Phon. 2008;22(12):957–973.
   PubMed Web of Science ®Google Scholar
• Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology. 2011;76(1):80–86.
   PubMed Web of Science ®Google Scholar
• Aldridge D, Theodoros D, Angwin A, et al. Speech outcomes in Parkinson’s disease after subthalamic nucleus deep brain stimulation: A systematic review. Parkinsonism Relat Disord. 2016;33:3–11.
   PubMed Web of Science ®Google Scholar
• Tsuboi T, Watanabe H, Tanaka Y, et al. Distinct phenotypes of speech and voice disorders in Parkinson’s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry. 2015;86(8):856–864.
   PubMed Web of Science ®Google Scholar
• Ramig LO, Countryman S, Thompson LL, et al. Comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hear Res. 1995;38(6):1232–1251.
   PubMedGoogle Scholar
• Ramig L, Halpern A, Spielman J, et al. Speech treatment in Parkinson’s disease: Randomized Controlled Trial (RCT). Mov Disord. 2018;33(11):1777–1791.
   PubMed Web of Science ®Google Scholar
• Grant LM, Richter F, Miller JE, et al. Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson’s disease. Behav Neurosci. 2014;128(2):110–121.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Lang AE, Gagnon JF, et al. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain. 2012;135(Pt 6):1860–1870.
   PubMed Web of Science ®Google Scholar
• Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol. 2009;66(1):39–47.
   PubMed Web of Science ®Google Scholar
• Tsanas A, Little MA, McSharry PE, et al. Nonlinear speech analysis algorithms mapped to a standard metric achieve clinically useful quantification of average Parkinson’s disease symptom severity. J R Soc Interface. 2011;8(59):842–855.
   PubMed Web of Science ®Google Scholar
• Tsanas A, Little MA, McSharry PE, et al. Novel speech signal processing algorithms for high-accuracy classification of Parkinson’s disease. IEEE Trans Biomed Eng. 2012;59(5):1264–1271.
   PubMed Web of Science ®Google Scholar
• Hlavnicka J, Cmejla R, Tykalova T, et al. Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder. Sci Rep. 2017;7(1):12.
   PubMedGoogle Scholar